This dosage information may not include all the information needed to use Rufinamide safely and effectively. See additional information for Rufinamide.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Lennox-Gastaut Syndrome
Initial dose: 400 to 800 mg/day administered in two equally divided doses.
The dose should be increased by 400 to 800 mg/day every 2 days until a maximum daily dose of 3200 mg/day, administered in two equally divided doses is reached. It is not known whether doses lower than 3200 mg are effective.
Usual Pediatric Dose for Lennox-Gastaut Syndrome
4 years or older:
Initial dose: daily dose of approximately 10 mg/kg/day administered in two equally divided doses.
The dose should be increased by approximately 10 mg/kg increments every other day to a target dose of 45 mg/kg/day or 3200 mg/day, whichever is less, administered in two equally divided doses. It is not known whether doses lower than the target doses are effective.
Renal Dose Adjustments
No adjustment recommended
Liver Dose Adjustments
Use of rufinamide in patients with hepatic impairment has not been studied. Use in patients with severe hepatic impairment is not recommended. Caution is recommended in treating patients with mild to moderate hepatic impairment.
Safety and effectiveness have not been established in pediatric patients less than 4 years of age.
No specific dose adjustment guidelines have been suggested. However, it should be noted that hemodialysis reduces plasma levels by about 30%.
Rufinamide tablets marketed as Banzel (R) are scored on both sides and can be cut in half for dosing flexibility. Banzel (R)tablets can be administered whole, as half tablets, or crushed.
Rufinamide should be administered with food.